Breaking News Instant updates and real-time market news.

MNST

Monster Beverage

$53.75

-0.45 (-0.83%)

, HLF

Herbalife Nutrition

$55.64

-0.57 (-1.01%)

07:30
03/25/19
03/25
07:30
03/25/19
07:30

Unusual put flow in option market yesterday

Notable put activity was cited Friday in Monster Beverage (MNST), Herbalife (HLF), TD Ameritrade (AMTD), Tapestry (TPR), and AES Corp. (AES).

MNST

Monster Beverage

$53.75

-0.45 (-0.83%)

HLF

Herbalife Nutrition

$55.64

-0.57 (-1.01%)

AMTD

TD Ameritrade

$49.60

-2.47 (-4.74%)

TPR

Tapestry

$31.10

-0.85 (-2.66%)

AES

AES Corp.

$18.06

-0.235 (-1.28%)

  • 18

    Apr

  • 24

    Apr

  • 24

    Apr

MNST Monster Beverage
$53.75

-0.45 (-0.83%)

03/12/19
BMOC
03/12/19
DOWNGRADE
Target $62
BMOC
Market Perform
Monster Beverage downgraded to Market Perform from Outperform at BMO Capital
BMO Capital analyst Amit Sharma downgraded Monster Beverage (MNST) to Market Perform from Outperform with an unchanged price target of $62. The stock closed yesterday up 58c to $61.19. Monster's current valuation, both absolute and relative to peers, "may be as good it gets," Sharma tells investors in a research note. Due to an "unfavorable" sales/product mix and emerging competition in the U.S. from Bang, as well as "disappointing" margin progression abroad, the analyst sees limited ability for the company to meaningfully exceed expectations and justify a higher valuation multiple. Red Bull is not following Monster on its recent price and also appears to be expanding its price cuts to the larger single-serve segment in Walmart (WMT), the analyst contends. Further, he points out that Bang is now capturing nearly 40% of energy drinks growth. Lastly, Sharma sees a "dwindling likelihood" of the "long-hoped-for" buyout of Monster Beverage by Coca-Cola (KO).
03/12/19
03/12/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Boeing (BA) downgraded to Hold from Buy at Edward Jones. 2. Monster Beverage (MNST) downgraded to Market Perform from Outperform at BMO Capital with analyst Amit Sharma saying Monster's current valuation, both absolute and relative to peers, "may be as good it gets." 3. Coca-Cola (KO) downgraded to Hold from Buy at HSBC with analyst Carlos Laboy saying in "trying to grow the pie," Coke is being required to drive revenues with low-margin brands that may take years to scale up. 4. HP Enterprise (HPE) downgraded to Sell from Neutral at UBS with analyst John Roy saying the company's on-premises hardware sales are being pressured by the growth in public cloud, while the "stock is expecting better." 5. F5 Networks (FFIV) downgraded to Neutral from Overweight at JPMorgan with analyst Samik Chatterjee saying the "expensive" acquisition of NGINX is "tough to digest" given the integration and execution risk. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/20/19
GSCO
03/20/19
DOWNGRADE
Target $59
GSCO
Neutral
Monster Beverage downgraded to Neutral from Conviction Buy at Goldman Sachs
Goldman Sachs analyst Judy Hong downgraded Monster Beverage to Neutral from Buy and removed the shares from her firm's Americas Conviction List. She also lowered her price target for the stock to $59 from $67. Monster closed yesterday down 4%, or $2.68, to $57.92. The company's U.S. sales could remain softer than expected in the near term, driving downward estimate revisions, Hong tells investors in a research note. Recent Nielsen data points to a "sizable slowing" in Monster's sales growth, says the analyst. She thinks heightened competition from Red Bull and continued growth from Bang are beginning to have a more sizable market share and sales impact on the company.
03/20/19
03/20/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Monster Beverage (MNST) downgraded to Neutral from Conviction Buy at Goldman Sachs with analyst Judy Hong saying the company's U.S. sales could remain softer than expected in the near term, driving downward estimate revisions. 2. FedEx (FDX) downgraded to Neutral from Overweight at JPMorgan with analyst Brian Ossenbeck noting FedEx's outlook was lowered more than expected as legacy Express leverage to a strong airfreight market was muted and the full TNT integration remains a second half of 2020 event. 3. Rockwell Automation (ROK) downgraded to Neutral from Buy at UBS with analyst Peter Lennox-King seeing a balanced risk/reward profile given the company's "decelerating growth outlook." 4. Teradata (TDC) downgraded to Sell from Neutral at Citi with analyst Tyler Radke saying shares are up over 20% since the company preannounced a strong Q4, but the quarter benefitted from one-offs. 5. Envestnet (ENV) downgraded to Neutral from Buy at DA Davidson with analyst Peter Heckmann noting the rebound in shares has taken valuation on the stock to more fair levels. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
HLF Herbalife Nutrition
$55.64

-0.57 (-1.01%)

02/26/19
JEFF
02/26/19
NO CHANGE
Target $65
JEFF
Buy
Herbalife Nutrition outlook likely to end up being conservative, says Jefferies
Despite softer than expected Q4 results and uncertainty around its China business, Herbalife Nutrition's fiscal 2019 guidance will likely end up being conservative owing to positive momentum in sales in most regions excluding China, Jefferies analyst Akshay Jagdale tells investors in a research note. The analyst continues to believe Herbalife can sustainably grow sales at least inline with its total addressable market growth rate of 6%, expand margins, and drive incremental earnings upside via accretive free cash flow usage. He keeps a Buy rating on the shares with a $65 price target.
01/04/19
ARGS
01/04/19
INITIATION
Target $72
ARGS
Buy
Herbalife Nutrition resumed with a Buy at Argus
Argus analyst John Staszak resumed Herbalife Nutrition with a Buy rating and a price target of $72, saying the company stands to benefit from "increased consumer interest in overall health and fitness, rather than just weight-loss products." The analyst is positive on the company's efforts to expand its product portfolio in capitalizing on that trend and relying more on coaching and educational programs to boost sales. Staszak further states that Herbalife's 2016 settlement with the FTC has likely resolved most of its legal and regulatory hurdles.
01/09/19
PIVT
01/09/19
NO CHANGE
Target $57
PIVT
Buy
Herbalife 'remains in good hands' despite loss of CEO, says Pivotal Research
Pivotal Research analyst Timothy Ramey made no changes to his estimates or $62 price target on Herbalife Nutrition shares following news that CEO Rich Goudis was forced out of his position due to comments he made that the company said "were inconsistent with Herbalife Nutrition's standards and do not reflect the company's culture." Ramey said Herbalife has "a strong management team with an excellent leadership group" and that he is "certain that the company remains in exceptionally strong hands." He keeps a Buy rating on Herbalife shares, which are down about 2% to $57 in pre-market trading.
01/09/19
JEFF
01/09/19
NO CHANGE
Target $65
JEFF
Buy
Herbalife Nutrition momentum intact despite CEO change, says Jefferies
While CEO transitions are seldom smooth, continuity should not be an issue with Herbalife Nutrition given the interim CEO ran the company from 2003 to 2017, Jefferies analyst Akshay Jagdale tells investors in a research note. The analyst also points out that the new CEO is expected to come from company's "strong/long tenured bench." Further, he is encouraged by Herbalife's "strong" Q4 volume performance and reaffirmation of its fiscal 2019 guidance. Jagdale believes Herbalife's business momentum is intact and he keeps a Buy rating on the shares with a $65 price target.
AMTD TD Ameritrade
$49.60

-2.47 (-4.74%)

01/29/19
MSCO
01/29/19
NO CHANGE
MSCO
Overweight
Morgan Stanley sees 'more to come' from discount brokers after strong Q4
Morgan Stanley analyst Michael Cyprys said the "strong" Q4 earnings reports from Charles Schwab (SCHW), E-Trade (ETFC) and TD Ameritrade (AMTD) showed that the discount brokers can grow revenues in a volatile, late-cycle backdrop. He increased his 2020 top-line estimates across the group, citing expectations for higher net interest margins and higher cash balances. Cyprys, who said the valuations in the group remain compelling on both an absolute and relative basis, keeps Overweight ratings on all three stocks mentioned. He raised his price target on Charles Schwab to $57 from $55, on E-Trade to $62 from $61 and on TD Ameritrade to $64 from $59.
01/22/19
MSCO
01/22/19
NO CHANGE
Target $57
MSCO
Overweight
Charles Schwab target raised to $57 ahead of winter update at Morgan Stanley
Morgan Stanley analyst Michael Cyprys said he has increased conviction in Charles Schwab (SCHW) shares after the company saw stronger organic deposit growth and broadly strong underlying growth metrics in Q4. He expects Charles Schwab to provide2019 guidance at the company's upcoming Winter Update on February 5 that should meet consensus expectations, but he also expects Schwab to beat those expectations over the course of 2019, as they havve done in prior years. He also expects Charles Schwab to give "more rational" pricing commentary this late in the cycle, which should support the stock and peers TD Ameritrade (AMTD) and E-Trade (ETFC), Cyprys tells investors. He raised his price target on Charles Schwab shares to $57 from $55 ahead of the update call and keeps an Overweight rating on the stock.
01/04/19
MSCO
01/04/19
NO CHANGE
MSCO
Morgan Stanley says buy TD Ameritrade ahead of earnings, negative on Virtu
Morgan Stanley analyst Michael Cyprys lowered his Q4 EPS estimates by 11% for the Asset Manager and Broker group given that the S&P 500 fell nearly 14% in the quarter, upending what had been a positive year for equity markets up until that point. For 2019, he favors the discount brokers - TD Ameritrade (AMTD), E-Trade (ETFC) and Charles Schwab (SCHW) - given their more defensive earnings profiles. Ahead of the Q4 earnings season he sees TD Ameritrade as "compelling" given its greater skew to trading revenues among the eBrokers, greater derivative mix and rising client cash levels, Cyprys tells investors. He also views concerns around commission price cuts as overdone as doe not expect Charles Schwab to cut, the analyst added. Ahead of Q4 reporting, Cyprys is negative on Virtu Financial (VIRT), as he thinks expectations are too high and notes the stock has recently outperformed.
11/30/18
GSCO
11/30/18
INITIATION
Target $60
GSCO
Neutral
TD Ameritrade initiated with a Neutral at Goldman Sachs
Goldman Sachs analyst Will Nance initiated coverage of the Online Brokers with an Attractive coverage view, stating that for the group on the whole he believes cyclical factors will drive fundamentals and valuation in the near term despite organic growth and pricing concerns. He started TD Ameritrade with a Neutral rating and $60 price target, stating that his estimates are roughly in-line with consensus. The bull thesis, that TD Ameritrade benefits the most in the group from more volatile markets and should see a multi-year increase in spread-based income, is largely reflected in consensus expectations, Nance believes.
TPR Tapestry
$31.10

-0.85 (-2.66%)

02/08/19
NEED
02/08/19
NO CHANGE
Target $42
NEED
Buy
Tapestry price target lowered to $42 from $50 at Needham
Needham analyst Rick Patel lowered his price target on Tapestry to $42, saying its Q2 results had "more bad than good". The analyst cites "weak comps at Kate" and gross margin miss at Coach overshadowing progress made at Stuart. Patel also keeps his Buy rating on Tapestry longer term and expects it to generate sales growth given the "long runways" at Kate and Stuart.
02/08/19
COWN
02/08/19
NO CHANGE
Target $42
COWN
Outperform
Tapestry price target lowered to $42 from $62 at Cowen
Cowen analyst Oliver Chen lowered his price target on Tapestry to $42 from $62 following Q2 results. The analyst believes the company may have taken a step backwards and valuation is likely to be held back in the near-term as Kate Spade results disappointed. He believes investors are likely to focus on new risks and global uncertainties and the company's ability to balance margin expansion versus growth. Chen maintained his Outperform rating on Tapestry shares.
02/08/19
ADAM
02/08/19
NO CHANGE
Target $41
ADAM
Buy
Tapestry price target lowered to $41 from $58 at Canaccord
Canaccord analyst Camilo Lyon lowered his price target on Tapestry to $41 from $58 following its Q2 miss, which he said was disappointing for many reasons, including brand disappointments. The analyst said the issues call into question the confidence he can put into the company achieving its EBIT growth target in 2020. However, Lyon maintained his Buy rating on Tapestry shares.
02/11/19
MKMP
02/11/19
NO CHANGE
Target $52
MKMP
Buy
Tapestry price target lowered to $52 from $63 at MKM Partners
MKM Partners analyst Roxanne Meyer lowered her price target on Tapestry to $52, reducing her implied multiple to 18-times her expected FY20 earnings from 20-times after its recent Q2 earnings miss and the disappointing guidance for the second half of FY19. The analyst also believes that Tapestry is a "dislocated stock" with a "misunderstood story" and recommends that investors buy shares now, noting that investors concerns over the management's ability to integrate of Kate Spade and the company's reduced visibility toward double-digit earnings growth at Coach in 2020 are not warranted.
AES AES Corp.
$18.06

-0.235 (-1.28%)

07/02/18
BOFA
07/02/18
DOWNGRADE
Target $12.5
BOFA
Underperform
AES Corp. downgraded to Underperform from Neutral at BofA/Merrill
BofA/Merrill analyst Jullen Dumoulin-Smith downgraded AES Corp to Underperform from Neutral and raised its price target to $12.50 from $12. The analyst believes valuation is excessive following successful strategic initiatives by management and is concerned about the difficult European backdrop, especially the treatment of Bulgarian PPAs, emerging market macro risks, and limited impact on shares from recent positive news.
05/16/18
05/16/18
DOWNGRADE
Target $12

Neutral
AES Corp. downgraded to Neutral on valuation at BofA/Merrill
As previously reported, BofA/Merrill downgraded AES Corp. to Neutral from Buy and trimmed its price target to $12 from $13. Analyst Julien Dumoulin-Smith views shares as fairly valued following the recent rally and believes management has executed well above expectations.
05/16/18
BOFA
05/16/18
DOWNGRADE
BOFA
Neutral
AES Corp. downgraded to Neutral from Buy at BofA/Merrill
05/09/18
SCOT
05/09/18
UPGRADE
SCOT
Sector Perform
AES Corp. upgraded to Sector Perform from Underperform at Scotiabank

TODAY'S FREE FLY STORIES

BILL

Bill.com

$0.00

(0.00%)

23:41
12/11/19
12/11
23:41
12/11/19
23:41
Syndicate
Bill.com 9.824M share IPO priced at $22.00 »

The deal size was raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

FTSV

Forty Seven

$36.00

1.4 (4.05%)

23:39
12/11/19
12/11
23:39
12/11/19
23:39
Syndicate
Forty Seven 4.86M share Spot Secondary priced at $35.00 »

Morgan Stanley and Credit…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

NCR

NCR Corp.

$32.60

0.16 (0.49%)

20:34
12/11/19
12/11
20:34
12/11/19
20:34
Hot Stocks
NCR enters consent decree to resolve claims related to Kalamazoo River matter »

NCR Corporation announces…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

CIEN

Ciena

$35.45

0.75 (2.16%)

, LOVE

Lovesac

$14.49

0.05 (0.35%)

20:25
12/11/19
12/11
20:25
12/11/19
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

CIEN

Ciena

$35.45

0.75 (2.16%)

LOVE

Lovesac

$14.49

0.05 (0.35%)

VERU

Veru

$2.47

0.17 (7.39%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 12

    Dec

  • 12

    Dec

  • 12

    Dec

  • 17

    Dec

  • 19

    Dec

CHEF

Chefs' Warehouse

$35.51

-0.06 (-0.17%)

20:24
12/11/19
12/11
20:24
12/11/19
20:24
Initiation
Chefs' Warehouse initiated at Piper Jaffray »

Chefs' Warehouse…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

HSBC

HSBC

$37.15

0.44 (1.20%)

20:13
12/11/19
12/11
20:13
12/11/19
20:13
Upgrade
HSBC rating change at BofA/Merrill »

HSBC upgraded to Buy from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PLCE

Children's Place

$54.36

-16.31 (-23.08%)

19:54
12/11/19
12/11
19:54
12/11/19
19:54
Downgrade
Children's Place rating change at Wedbush »

Children's Place…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

LVGO

Livongo Health

$27.55

1.48 (5.68%)

19:43
12/11/19
12/11
19:43
12/11/19
19:43
Syndicate
Livongo Health 2.78M share Secondary priced at $27.00 »

The deal priced below the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

CVX

Chevron

$116.22

-1.68 (-1.42%)

19:42
12/11/19
12/11
19:42
12/11/19
19:42
Periodicals
Chevron said to be close to approving Gulf of Mexico project, Bloomberg says »

Bloomberg's Kevin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RH

RH

$233.00

0.03 (0.01%)

19:27
12/11/19
12/11
19:27
12/11/19
19:27
Hot Stocks
RH CEO sold 500,000 common shares of company from Dec 9 through Dec 11 »

RH announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRWD

Crowdstrike

$47.74

0.18 (0.38%)

19:17
12/11/19
12/11
19:17
12/11/19
19:17
Hot Stocks
Crowdstrike CFO sells 215K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 09

    Dec

GLD

SPDR Gold Shares

$138.94

0.98 (0.71%)

19:00
12/11/19
12/11
19:00
12/11/19
19:00
Hot Stocks
SPDR Gold Shares holdings rise to 886.22MT from 885.93MT »

This is the first…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIS

Disney

$147.70

1.58 (1.08%)

, GOOG

Alphabet

$1,345.14

0.64 (0.05%)

18:59
12/11/19
12/11
18:59
12/11/19
18:59
Periodicals
Disney Plus was Google's most searched term in U.S. this year, TechCrunch says »

In the United States in…

DIS

Disney

$147.70

1.58 (1.08%)

GOOG

Alphabet

$1,345.14

0.64 (0.05%)

GOOGL

Alphabet Class A

$1,344.65

1.61 (0.12%)

AAPL

Apple

$270.71

2.09 (0.78%)

T

AT&T

$38.17

0.1 (0.26%)

NFLX

Netflix

$299.25

6.04 (2.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 29

    Jan

DLHC

DLH Holdings

$4.58

0.525 (12.96%)

, FORM

FormFactor

$23.77

0.57 (2.46%)

18:57
12/11/19
12/11
18:57
12/11/19
18:57
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS: DLH…

DLHC

DLH Holdings

$4.58

0.525 (12.96%)

FORM

FormFactor

$23.77

0.57 (2.46%)

LULU

Lululemon

$233.31

3.75 (1.63%)

NX

Quanex

$19.72

0.68 (3.57%)

TLRD

Tailored Brands

$4.85

-0.42 (-7.97%)

NDSN

Nordson

$167.44

1.69 (1.02%)

MESA

Mesa Air

$9.25

0.17 (1.87%)

OXM

Oxford Industries

$74.07

-1.89 (-2.49%)

AKTS

Akoustis

$7.60

0.11 (1.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 11

    Dec

  • 11

    Dec

  • 11

    Dec

  • 12

    Dec

  • 12

    Dec

  • 12

    Dec

  • 18

    Dec

TTD

Trade Desk

$250.44

0.13 (0.05%)

18:57
12/11/19
12/11
18:57
12/11/19
18:57
Hot Stocks
Trade Desk CEO: We don't own any media »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RACE

Ferrari

$165.20

0.37 (0.22%)

18:45
12/11/19
12/11
18:45
12/11/19
18:45
Hot Stocks
Ferrari enters into new EUR 350M credit facility »

Ferrari announces that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RIBT

RiceBran

$2.09

-0.105 (-4.79%)

18:43
12/11/19
12/11
18:43
12/11/19
18:43
Syndicate
RiceBran offers to sell common stock, no amount given »

Lake Street Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VMW

VMware

$151.00

2.27 (1.53%)

, TSLA

Tesla

$352.40

3.58 (1.03%)

18:42
12/11/19
12/11
18:42
12/11/19
18:42
Hot Stocks
VMware's Poonen: Our networking business is on fire »

In an interview on…

VMW

VMware

$151.00

2.27 (1.53%)

TSLA

Tesla

$352.40

3.58 (1.03%)

DELL

Dell Technologies

$47.73

0.37 (0.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 11

    Dec

  • 12

    Dec

  • 07

    Jan

  • 08

    Jan

  • 09

    Jan

  • 27

    Feb

SMTC

Semtech

$47.36

0.48 (1.02%)

18:38
12/11/19
12/11
18:38
12/11/19
18:38
Hot Stocks
Semtech director sells 19.3K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

CS

Credit Suisse

$12.95

-0.115 (-0.88%)

18:29
12/11/19
12/11
18:29
12/11/19
18:29
Periodicals
Former Credit Suisse JV exec claims she was put under surveillance, WSJ says »

Colleen Graham, a former…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

PANW

Palo Alto Networks

$226.76

1.71 (0.76%)

18:22
12/11/19
12/11
18:22
12/11/19
18:22
Hot Stocks
Palo Alto Networks CEO: No systematic problem with our sales »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Jan

PBYI

Puma Biotechnology

$8.71

0.24 (2.83%)

18:08
12/11/19
12/11
18:08
12/11/19
18:08
Hot Stocks
Puma Biotechnology presents Phase II results of neratinib in breast cancer »

Puma Biotechnology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GTHX

G1 Therapeutics

$23.06

-0.18 (-0.77%)

18:05
12/11/19
12/11
18:05
12/11/19
18:05
Hot Stocks
G1 Therapeutics presents data from Phase 1b/2a trial of lerociclib at SABCS »

G1 Therapeutics reported…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NH

NantHealth

$0.86

-0.0225 (-2.54%)

18:01
12/11/19
12/11
18:01
12/11/19
18:01
Hot Stocks
NantHealth presents new breast cancer research findings at SABCS »

NantHealth announced new…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWTR

Twitter

$30.56

0.71 (2.38%)

, AAPL

Apple

$270.71

2.09 (0.78%)

17:51
12/11/19
12/11
17:51
12/11/19
17:51
Hot Stocks
Twitter announces support for iOS Live Photos that will show as GIFs »

Earlier today Twitter…

TWTR

Twitter

$30.56

0.71 (2.38%)

AAPL

Apple

$270.71

2.09 (0.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.